Company Search:
Advanced Search
Sponsored Links
Hisamitsu Pharmaceutical Co Inc Company Snapshot
Hisamitsu Pharmaceutical Co Inc operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hisamitsu Pharmaceutical Co Inc with three other companies in this sector in Japan: Daito Pharmaceutical Company Limited (2017 sales of 37.98 billion Japanese Yen [US$358.19 million] of which 59% was Drug Substance), Moriroku Holdings Co Ltd (170.01 billion Japanese Yen [US$1.60 billion] of which 62% was Resin processing products business), and Kissei Pharmaceutical Company Limited (71.71 billion Japanese Yen [US$676.19 million] of which 86% was Pharmaceutical Products).

Sales Analysis. Hisamitsu Pharmaceutical Co Inc reported sales of ¥145.93 billion (US$1.38 billion) for the fiscal year ending February of 2017. This represents a decrease of 9.8% versus 2016, when the company's sales were ¥161.85 billion. The sales level in 2017 was fairly close to the level five years ago: in 2012, Hisamitsu Pharmaceutical Co Inc had sales of ¥137.79 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hisamitsu Pharmaceutical Co Inc
  Stock Performance Chart for Hisamitsu Pharmaceutical Co Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 8,190.00
(Figures in Japanese Yen)
1 Week 8.6%   13 Weeks 11.9%  
4 Weeks 26.2%   52 Weeks 31.0%  
Hisamitsu Pharmaceutical Co Inc Key Data:
  Ticker: 4530 Country: Japan
  Exchanges: TYO OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 145,925,000,000
(Year Ending Jan 2018).
Employees: 2,751
  Currency: Japanese Yen Market Cap: 685,216,268,100
  Fiscal Yr Ends: February Shares Outstanding: 83,664,990
  Share Type: Common Closely Held Shares: 17,304,982
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.